Clinical Trial Update: Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death [Phase 2]

View source ↗

Summary

A completed Phase 2 dose-ranging study evaluating Celivarone with amiodarone as a calibrator to prevent ICD interventions or death from ventricular arrhythmias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Ventricular Arrhythmia

Drugs mentioned

• Amiodarone (amiodarone)
• Celivarone (celivarone)

Snippet

Sponsor: Sanofi | Conditions: Arrhythmia Prophylaxis, Ventricular Arrhythmia | Phase 2 | Status: COMPLETED